78 related articles for article (PubMed ID: 20855666)
41. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.
Cohen DJ; Lincoff AM; Lavelle TA; Chen HL; Bakhai A; Berezin RH; Jackman D; Sarembock IJ; Topol EJ
J Am Coll Cardiol; 2004 Nov; 44(9):1792-800. PubMed ID: 15519009
[TBL] [Abstract][Full Text] [Related]
42. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
Lincoff AM; Kleiman NS; Kereiakes DJ; Feit F; Bittl JA; Jackman JD; Sarembock IJ; Cohen DJ; Spriggs D; Ebrahimi R; Keren G; Carr J; Cohen EA; Betriu A; Desmet W; Rutsch W; Wilcox RG; de Feyter PJ; Vahanian A; Topol EJ;
JAMA; 2004 Aug; 292(6):696-703. PubMed ID: 15304466
[TBL] [Abstract][Full Text] [Related]
43. Drug-induced immune thrombocytopenia.
Naina HV; Harris S
N Engl J Med; 2007 Nov; 357(18):1869-70; author reply 1871. PubMed ID: 17978299
[No Abstract] [Full Text] [Related]
44. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
[TBL] [Abstract][Full Text] [Related]
45. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Khan MH; Khan MA; Fail PS; Vivekananthan K; Allie SE; Mitran EV; Chaisson G; Stagg SJ; Allie AA; McElderry MW; Barker EA; Walker CM
J Invasive Cardiol; 2005 Aug; 17(8):427-32. PubMed ID: 16079449
[TBL] [Abstract][Full Text] [Related]
46. Balancing the risks of stent thrombosis and major bleeding during primary percutaneous coronary intervention.
Gutierrez A; Bhatt DL
Eur Heart J; 2014 Sep; 35(36):2448-51. PubMed ID: 24864080
[No Abstract] [Full Text] [Related]
47. Oldies but goodies.
Butman SM
Catheter Cardiovasc Interv; 2009 Sep; 74(3):436-7. PubMed ID: 19681122
[No Abstract] [Full Text] [Related]
48. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
Lemesle G; De Labriolle A; Bonello L; Syed A; Collins S; Maluenda G; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2009 Sep; 74(3):428-35. PubMed ID: 19360860
[TBL] [Abstract][Full Text] [Related]
49. Bivalirudin in acute coronary syndromes.
Sanmartin M
N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
[No Abstract] [Full Text] [Related]
50. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.
Exaire JE; Butman SM; Ebrahimi R; Kleiman NS; Harrington RA; Schweiger MJ; Bittl JA; Wolski K; Topol EJ; Lincoff AM;
Am Heart J; 2006 Jul; 152(1):157-63. PubMed ID: 16824849
[TBL] [Abstract][Full Text] [Related]
51. Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).
Chew DP; Lincoff AM; Gurm H; Wolski K; Cohen DJ; Henry T; Feit F; Topol EJ;
Am J Cardiol; 2005 Mar; 95(5):581-5. PubMed ID: 15721095
[TBL] [Abstract][Full Text] [Related]
52. Antithrombotic therapy to support primary PCI.
Morrow DA
N Engl J Med; 2008 May; 358(21):2280-2. PubMed ID: 18499573
[No Abstract] [Full Text] [Related]
53. What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?
Brodie BR
Catheter Cardiovasc Interv; 2008 May; 71(6):816-21. PubMed ID: 18412079
[TBL] [Abstract][Full Text] [Related]
54. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
[TBL] [Abstract][Full Text] [Related]
55. Renal transplantation in a patient with catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia.
Podolak B; Blickstein D; Inbal A; Eizner S; Rahamimov R; Yussim A; Mor E
Isr Med Assoc J; 2014 Jan; 16(1):61-2. PubMed ID: 24575510
[No Abstract] [Full Text] [Related]
56. Bilateral adrenal hemorrhages in a patient with heparin-induced thrombocytopenia.
Montealegre-Gallegos M; Bose S
CMAJ; 2019 Nov; 191(44):E1222. PubMed ID: 31685666
[No Abstract] [Full Text] [Related]
57. Bivalirudin for carotid artery stenting: a new approach on the HORIZON(s)?
Armstrong EJ; Laird JR
Circ Cardiovasc Interv; 2013 Apr; 6(2):125-7. PubMed ID: 23591418
[No Abstract] [Full Text] [Related]
58. Argatroban for off-pump coronary artery bypass surgery.
Nielsen VG
Anesth Analg; 2003 Oct; 97(4):1201-1202. PubMed ID: 14500190
[No Abstract] [Full Text] [Related]
59. Letter by Boschetti et al regarding article, "Predictors of outcome in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Substudy".
Boschetti E; De Paolis M; Piccioni F
Circulation; 2010 Nov; 122(20):e523. PubMed ID: 21098465
[No Abstract] [Full Text] [Related]
60. Letter by Correia and Barreto-Filho regarding article, "Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Substudy".
Correia LC; Barreto-Filho JA
Circulation; 2010 Nov; 122(20):e522. PubMed ID: 21098464
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
